围绝经期转换至整合酶链转移抑制剂与HIV感染女性体成分加速改变相关
该研究纳入1131名病毒抑制的HIV感染女性(419名转换至INSTI,712名未转换)和887名无HIV女性,评估围绝经期分期中腰围和BMI变化。结果显示,在绝经后期和绝经期转换至INSTI者腰围增加更快,与未转换者相比差异有统计学意义,提示转换INSTI时应考虑绝经状态。
要点
- 绝经后期转换INSTI者腰围每6个月增加0.37 cm(95%CI 0.15-0.60),未转换者为0.14 cm(95%CI -0.06-0.34)。
- 与未转换者相比,绝经后期转换INSTI者腰围线性增加快0.26 cm/6个月(95%CI 0.02-0.50)。
- 绝经期转换INSTI者腰围增加更快,于41个月达峰;未转换者增加较小(0.14 cm/6个月,95%CI -0.02-0.30)。
主要发现
- 绝经前期,HIV感染女性腰围增加(INSTI+:0.01 cm/6个月,95%CI -0.29-0.32;INSTI-:0.22 cm/6个月,95%CI -0.01-0.44),与无HIV女性无统计学显著差异,且按INSTI状态差异很小。
- 绝经后期,与无HIV女性相比,INSTI+腰围增加更快(0.37 cm/6个月,95%CI 0.15-0.60),INSTI-增加较小(0.14 cm/6个月,95%CI -0.06-0.34)。
- 绝经期,INSTI+腰围增加更快,于43个月达峰后下降;INSTI-增加较小(0.14 cm/6个月,95%CI -0.02-0.30)。
- 与INSTI-相比,绝经后期INSTI+腰围线性增加快0.26 cm/6个月(95%CI 0.02-0.50);绝经期INSTI+与更快增加相关,于41个月达峰。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Integrase strand transfer inhibitors (INSTIs) and the menopausal transition have been associated with body composition changes in women with human immunodeficiency virus (WWH), but their interaction is unknown. METHODS: From 2006 to 2019, 1131 virally-suppressed WWH (419 who switched to INSTI [INSTI+]; 712 who did not switch [INSTI-]) and 887 women without HIV (WWOH) from the Women's Interagency HIV Study were included. Mixed-effects models were used to evaluate change in waist circumference (WC) and body mass index (BMI) by menopausal phase defined using anti-Müllerian hormone, a biomarker of ovarian reserve. RESULTS: During premenopause, WWH had increases in WC (INSTI+: 0.01 cm per 6 months [95% confidence interval {CI}: -.29 to .32] and INSTI-: 0.22 cm per 6 months [95% CI: -.01 to .44]) that were not statistically significantly different from WWOH; there was also little difference by INSTI status. In late perimenopause, INSTI+ had faster increases in WC (0.37 cm per 6 months [95% CI: .15-.60]) while INSTI- had smaller increases (0.14 cm per 6 months [95% CI: -.06 to .34]) compared to WWOH. In menopause, INSTI+ had faster increases, peaking at 43 months then declining, while INSTI- had smaller increases (0.14 cm per 6 months [95% CI: -.02 to .30]). Compared to INSTI-, in late perimenopause, INSTI+ had 0.26 cm per 6 months (95% CI: .02-.50) faster linear increases in WC and in menopause, INSTI+ was associated with faster increases, peaking at 41 months. CONCLUSIONS: Switching to an INSTI-based regimen during late perimenopause and menopause is associated with faster increases in WC when compared to women who did not switch. Menopausal status should be considered when switching to an INSTI.
引用
- Abelman RA, Ma Y, Mehta CC, et al. Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV. Clin Infect Dis. 2025. PMID: 39495675. doi:10.1093/cid/ciae540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。